3/14
01:32 am
fhtx
Low
Report
3/12
07:01 pm
fhtx
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/12
11:22 am
fhtx
Foghorn Therapeutics (FHTX) had its "outperform" rating reaffirmed by Wedbush. They now have a $10.00 price target on the stock.
Low
Report
Foghorn Therapeutics (FHTX) had its "outperform" rating reaffirmed by Wedbush. They now have a $10.00 price target on the stock.
3/11
04:44 pm
fhtx
Foghorn Therapeutics GAAP EPS of -$1.18 misses by $0.08, revenue of $30.91M misses by $0.31M [Seeking Alpha]
High
Report
Foghorn Therapeutics GAAP EPS of -$1.18 misses by $0.08, revenue of $30.91M misses by $0.31M [Seeking Alpha]
3/11
04:22 pm
fhtx
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook [Yahoo! Finance]
High
Report
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook [Yahoo! Finance]
3/11
04:09 pm
fhtx
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
High
Report
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
3/10
08:03 am
fhtx
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.
2/24
07:23 am
fhtx
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
3/11/2026
04:09 pm
fhtx
foghorn therapeutics inc.
MISS
Report
-12.9%
foghorn therapeutics inc.
11/5/2025
07:00 am
fhtx
foghorn therapeutics inc.
BEAT
Report
16.3%
foghorn therapeutics inc.
5/14/2025
07:00 am
fhtx
foghorn therapeutics inc.
IN-LINE
Report
-3.3%
foghorn therapeutics inc.
3/11
04:12 pm
fhtx
Form 10-K Foghorn Therapeutics For: Dec 31
High
Report
Form 10-K Foghorn Therapeutics For: Dec 31
3/11
04:09 pm
fhtx
Form 8-K Foghorn Therapeutics For: Mar 11
High
Report
Form 8-K Foghorn Therapeutics For: Mar 11
2/24
04:03 pm
fhtx
Form 4 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
Low
Report
Form 4 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
2/24
04:01 pm
fhtx
Form 3 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
Low
Report
Form 3 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
2/23
07:00 am
fhtx
Form 8-K Foghorn Therapeutics For: Feb 23
Low
Report
Form 8-K Foghorn Therapeutics For: Feb 23
2/6
04:01 pm
fhtx
Form 4 Foghorn Therapeutics For: Feb 05 Filed by: GOTTSCHALK ADRIAN
Medium
Report
Form 4 Foghorn Therapeutics For: Feb 05 Filed by: GOTTSCHALK ADRIAN
2/2
04:05 pm
fhtx
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Costa Carlos
Low
Report
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Costa Carlos
2/2
04:04 pm
fhtx
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: LaCascia Michael
Low
Report
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: LaCascia Michael
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register